• English
  • 简体中文
Login Register
Current Location: Home > FDA Approved Drug Products Feedback Help
-
-
Application Number Application Type Drug Name Active Ingredients Dosage Form/Route Approval Date Company
216212 ANDA ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN ETHYLSUCCINATE GRANULE;ORAL 2022-11-21 CADILA PHARMS LTD
216066 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL 2022-07-13 ALKEM LABS LTD
215661 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL ALEMBIC
215440 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL ZYDUS PHARMS
215290 ANDA ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION 2022-02-14 NEXUS
214549 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL 2021-02-11 TEVA PHARMS USA INC
213628 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL 2021-06-28 CADILA PHARMS LTD
212693 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL 2023-03-07 ZYDUS LIFESCIENCES
212015 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL 2020-07-06 TORRENT
211991 ANDA ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN ETHYLSUCCINATE GRANULE;ORAL 2019-10-23 PAR PHARM INC
211975 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET, DELAYED RELEASE;ORAL 2021-07-26 TORRENT
211204 ANDA ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN ETHYLSUCCINATE GRANULE;ORAL 2019-11-01 AMNEAL PHARMS
211086 ANDA ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION 2020-09-17 EXELA PHARMA
210954 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET, DELAYED RELEASE;ORAL 2019-07-02 AMNEAL PHARMS CO
209720 ANDA ERYTHROMYCIN ERYTHROMYCIN TABLET;ORAL 2018-03-09 AMNEAL PHARMS CO
208154 ANDA ERYTHROMYCIN ERYTHROMYCIN GEL;TOPICAL 2017-07-19 ENCUBE
208100 ANDA ERYTHROMYCIN ERYTHROMYCIN SOLUTION;TOPICAL 2017-11-20 PAI HOLDINGS PHARM
090215 ANDA ERYTHROMYCIN ERYTHROMYCIN SWAB;TOPICAL 2010-05-12 EPIC PHARMA LLC
065385 ANDA ERYTHROMYCIN AND BENZOYL PEROXIDE BENZOYL PEROXIDE; ERYTHROMYCIN GEL;TOPICAL 2015-09-18 LYNE
065320 ANDA ERYTHROMYCIN ERYTHROMYCIN SWAB;TOPICAL 2006-07-25 FOUGERA PHARMS